Zoetis Inc. ZTS
71.05
0.78
1.11%
as of 25 Sep
- Market cap
- $29.2B
- P/E
- 11.7×
Follow ZTS
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
Zoetis Inc. (ZTS) Revenue growth
Zoetis Inc.'s revenue growth over the twelve months to 30 June 2026 was 1.58%, down 0.7 percentage points from fiscal 2025 (2.28%). Over the past ten years it has ranged from −0.42% (fiscal 2015) to 16.5% (fiscal 2021); the current reading is higher than 18% of that period. That is below the Drug Manufacturers Specialty & Generic industry median of 10.0% and below the Healthcare sector median of 8.26%.
Revenue growth, annual
Annual
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2025 | 2.28% | (6.05) |
| FY2024 | 8.33% | 2.59 |
| FY2023 | 5.74% | 1.83 |
| FY2022 | 3.91% | (12.58) |
| FY2021 | 16.5% | 9.86 |
| FY2020 | 6.63% | (0.84) |
| FY2019 | 7.47% | (2.29) |
| FY2018 | 9.76% | 1.19 |
| FY2017 | 8.57% | 5.99 |
| FY2016 | 2.58% | 3.00 |
Quarterly
| Period | Revenue growth | Change (points) |
|---|---|---|
| Jun 2026 | −0.24% | (3.15) |
| Mar 2026 | 2.91% | (0.46) |
| Dec 2025 | 3.37% | 2.87 |
| Sep 2025 | 0.50% | (4.29) |
| 42 more quarters | Free account |
Against its own ten years
Low −0.42%
High 16.5%
Ten-year median
6.63%
Current reading's percentile
18
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| NBIX Neurocrine Biosciences, Inc. compare | 34.4% |
| ELAN Elanco Animal Health Incorporated compare | 12.0% |
| VTRS Viatris Inc. compare | 4.40% |
| TEVA Teva Pharmaceutical Industries Ltd. compare | 4.13% |
| UTHR United Therapeutics Corporation compare | 2.49% |
| ZTS Zoetis Inc. | 1.58% |
| TAK Takeda Pharmaceutical Co. compare | 0.66% |
| RDY Dr. Reddy's Laboratories Ltd compare | −11.6% |
| HLN Haleon PLC Sponsored ADR compare | — |
| Drug Manufacturers Specialty & Generic industry median | 10.0% |
| Healthcare sector median | 8.26% |
| Market median | 7.41% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on ZTS
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- The full statement